Merck Advances Oncology Portfolio and Pipeline with New and Lo...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
DARMSTADT, Germany, Sept. 14, 2020 /PRNewswire-AsiaNet/ -- -New analyses from Phase III JAVELIN Bladder 100 study of BAVENCIO(R)* assess efficacy across subgroups, patient-reported outcomes and exploratory biomarkers in advanced urothelial cancer-Overall efficacy data, and analyses of brain metastas...
Authors: LATEST ASIANET NEWS RELEASES